XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of the Company’s Assets and Liabilities that are Measured and Recognized at Fair Value on a Recurring Basis Classified Under the Appropriate Level of the Fair Value Hierarchy
The following table presents the Company’s assets and liabilities that are measured and recognized at fair value on a recurring basis classified under the appropriate level of the fair value hierarchy as of March 31, 2023, and December 31, 2022:
 
Fair Value Measurements at
March 31, 2023
(in thousands)Quoted Prices in Active Markets for Identical Assets and Liabilities
(Level 1)
Significant Other Observable Inputs
(Level 2)
Significant Unobservable Inputs
(Level 3)
Total
Assets:
Money market fund$14,158 $— $— $14,158 
Total included in cash and cash equivalents14,158 — — 14,158 
Available for sale investments:
Certificate of deposit— 13,925 — 13,925 
Corporate debt securities— 32,828 — 32,828 
    Commercial paper— 10,398 — 10,398 
U.S. government agencies— 7,842 7,842 
U.S. treasury securities16,958 — — 16,958 
Total available for sale investments (1)16,958 64,993 — 81,951 
Total assets measured at fair value on a recurring basis$31,116 $64,993 $— $96,109 
Fair Value Measurements at
December 31, 2022
(in thousands)Quoted Prices in Active Markets for Identical Assets and Liabilities
(Level 1)
Significant Other Observable Inputs
(Level 2)
Significant Unobservable Inputs
(Level 3)
Total
Assets:
Money market fund$15,722 $— $— $15,722 
Total included in cash and cash equivalents15,722 — — 15,722 
Available for sale investments:
Certificate of deposit— 16,023 — 16,023 
Corporate debt securities— 49,535 — 49,535 
    Commercial paper— 13,187 — 13,187 
U.S. government agencies— 2,288 — 2,288 
U.S. treasury securities7,887 — — 7,887 
Total available for sale investments (1)7,887 81,033 — 88,920 
Total assets measured at fair value on a recurring basis$23,609 $81,033 $— $104,642 
(1) Included in short-term investments in the accompanying balance sheets.